Literature DB >> 798190

Higher than usual dosage of haloperidol: a pilot study in chronic schizophrenics.

M Pacquay, F Brasseur.   

Abstract

The effect of higher than usual dosages of haloperidol was studied in 38 chronic institutionalized schizophrenic patients for whom any hope of discharge had been abandoned. In 23 patients (61%) a marked or moderate improvement was observed. No striking differences were seen between patients simultaneously receiving or not receiving group therapy. The 15 remaining patients put on haloperidol alone showed some increase in psychomotor alertness, according to the nurses' judgement. It is clear from these results can be safely administered and can be of considerable value in chronic institutionalized schizophrenic patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 798190      PMCID: PMC1863623     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


  5 in total

1.  Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.

Authors:  H Huygens; J L Vereecken; A Tanghe
Journal:  Psychiatr Neurol Neurochir       Date:  1973 Jul-Aug

2.  End of a back ward: the rapid rehabilitation and release of chronically hospitalized psychiatric patients.

Authors:  J S Howard; K T Schmidt
Journal:  Psychosomatics       Date:  1973 Nov-Dec       Impact factor: 2.386

3.  Dexbenzetimide in neuroleptic-induced parkinsonism. A double-blind crossover study with a 16-week follow-up.

Authors:  R De Smedt; E Rodrigus; R Debandt; J Brugmans
Journal:  J Clin Pharmacol J New Drugs       Date:  1970 May-Jun

4.  Benzetimide and its optical isomers.

Authors:  P A Janssen; C J Niemegeers; K H Schellekens; P Demoen; F M Lenaerts; J M Van Nueten; I Van Wijngaarden; J Brugmans
Journal:  Arzneimittelforschung       Date:  1971-09

5.  [Long-acting antiparkinson agents. I. Pilot study on benzetimide (342 cases)].

Authors:  M Korn; A Pinchard; M Breulet; F Goffioul; J Bobon
Journal:  Acta Psychiatr Belg       Date:  1971-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.